Cutler Group’s Elevance Health ELV Stock Holding History

Cutler Group’s Portfolio ELV Stock Details ELV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-46	Closed	-$20K	–	4589
2022 Q3	$20K	Hold	46	–	–	﹤0.01%	2605
2022 Q2	$22K	Buy	+46	New	+$22.8K	﹤0.01%	2586
2021 Q4	–	Sell	-590	Closed	-$248K	–	5524
2021 Q3	$219K	Sell	590 -289	-33%	-$110K	0.01%	1295
2021 Q2	$335K	Buy	879 +100	+13%	+$38.2K	0.02%	983
2021 Q1	$279K	Buy	779 +466	+149%	+$150K	0.01%	1058
2020 Q4	$100K	Sell	313 -1,599	-84%	-$491K	﹤0.01%	1528
2020 Q3	$513K	Buy	1,912 +213	+13%	+$57.3K	0.03%	527
2020 Q2	$446K	Buy	1,699 +718	+73%	+$192K	0.03%	531
2020 Q1	$222K	Sell	981 -4,171	-81%	-$1.14M	0.01%	886
2019 Q4	$1.56M	Buy	5,152 +482	+10%	+$133K	0.1%	189
2019 Q3	$1.12M	Sell	4,670 -1,562	-25%	-$428K	0.1%	178
2019 Q2	$1.76M	Buy	6,232 +5,305	+572%	+$1.45M	0.16%	101
2019 Q1	$266K	Buy	+927	New	+$268K	0.03%	536
2016 Q4	–	Sell	-1,445	Closed	-$193K	–	6687
2016 Q3	$181K	Sell	1,445 -1,709	-54%	-$221K	0.01%	1303
2016 Q2	$414K	Buy	+3,154	New	+$432K	0.02%	686

Other funds holding ELV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Sanders Capital West Palm Beach, Florida $99.8B AUM 47.9% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Cutler Group's ELV Position: Q4 2022 in Review

Cutler Group sold out of Elevance Health (ELV) in Q4 2022, closing a stake of 46 shares — an estimated $20K sold.

Cutler Group first reported a position in ELV in Q2 2016 and held it in 15 quarters. The position peaked at $1.76M in Q2 2019. 1,548 funds tracked by Wall St. Rank hold ELV as of Q4 2022.

Cutler Group reported no remaining Elevance Health position as of Q4 2022 after selling out during the quarter.
Cutler Group sold 46 Elevance Health shares in Q4 2022, an estimated $20K.
Cutler Group first reported a position in Elevance Health in Q2 2016 and held it in 15 quarters.
Cutler Group's Elevance Health position peaked at $1.76M in Q2 2019.
1,548 funds tracked by Wall St. Rank held Elevance Health as of Q4 2022.

Based on Cutler Group's 13F filing for Q4 2022, filed 7 Feb 2023.